← Open Payments lookup

SIMONE JACKSON: Open Payments

NPI 1134644396 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,208 in 111 payments from 9 companies in 2025. Trend: 2023 $1,755 · 2024 $2,156 · 2025 $2,208

Food & beverage: $2,208
CompanyPaymentsAmount
Alkermes, Inc.23$592
Neurocrine BioSciences, Inc.16$340
Otsuka America Pharmaceutical, Inc.15$270
E.R. Squibb & Sons, L.L.C.13$268
Teva Pharmaceuticals USA, Inc.17$239
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$232
Janssen Pharmaceuticals, Inc6$106
ABBVIE INC.4$91
Vanda Pharmaceuticals Inc.3$69

Products named: ARISTADA, INGREZZA, COBENFY, REXULTI, CAPLYTA, AUSTEDO XR, LYBALVI, INVEGA SUSTENNA.

Industry payments across NV — which companies pay providers there.